![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2020
Andlauer, Till F. M.; Link, Jenny; Martin, Dorothea; Ryner, Malin; Hermanrud, Christina; Grummel, Verena; Auer, Michael; Hegen, Harald; Aly, Lilian; Gasperi, Christiane; Knier, Benjamin; Mueller-Myhsok, Bertram; Jensen, Poul Erik Hyldgaard; Sellebjerg, Finn; Kockum, Ingrid; Olsson, Tomas; Pallardy, Marc; Spindeldreher, Sebastian; Deisenhammer, Florian; Fogdell-Hahn, Anna und Hemmer, Bernhard
(2020):
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS.
In: BMC Medicine, Bd. 18, Nr. 1, 298
[PDF, 1MB]
2016
Bachelet, Delphine; Hässler, Signe; Mbogning, Cyprien; Link, Jenny; Ryner, Malin; Ramanujam, Ryan; Auer, Michael; Jensen, Poul Erik Hyldgaard; Koch-Henriksen, Nils; Warnke, Clemens; Ingenhoven, Kathleen; Buck, Dorothea; Grummel, Verena; Lawton, Andy; Donnellan, Naoimh; Hincelin-Mery, Agnes; Sikkema, Dan; Pallardy, Marc; Kieseier, Bernd; Hemmer, Bernard; Hartung, Hans Peter; Sorensen, Per Soelberg; Deisenhammer, Florian; Dönnes, Pierre; Davidson, Julie; Fogdell-Hahn, Anna und Broet, Philippe
(2016):
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
In: PLOS ONE 11(11), e0162752 [PDF, 2MB]
In: PLOS ONE 11(11), e0162752 [PDF, 2MB]